Stock Hero Advertisement
Home > Boards > US Listed > Biotechs > Mast Therapeutics, Inc. (MSTX)

thanks appreciate the response, I am long here,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BISerNOMORE Member Profile
 
Followed By 67
Posts 5,328
Boards Moderated 0
Alias Born 03/17/10
160x600 placeholder
Advertisement
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/29/2015 4:11:17 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/29/2015 4:08:11 PM
Roth Capital Initiates Coverage on Mast Therapeutics (MSTX) "Analyst Ratings Network" - 4/24/2015 4:56:14 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/23/2015 9:01:37 AM
Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark "PR Newswire (US)" - 4/21/2015 8:00:00 AM
Mast To Present New Data Supporting Vepoloxamer (MST-188) In Sickle Cell Disease At 9th Annual Sickle Cell Disease Research A... "PR Newswire (US)" - 4/9/2015 8:00:00 AM
Mast Therapeutics - Small-Cap Biotech Stock With Big Potential "Seeking Alpha" - 4/5/2015 3:37:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 8:44:01 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 3/24/2015 4:52:57 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/24/2015 8:31:45 AM
Mast Therapeutics Q4 and FY14 results "Seeking Alpha" - 3/24/2015 8:13:17 AM
Mast Therapeutics beats by $0.01 "Seeking Alpha" - 3/24/2015 8:03:59 AM
Mast Therapeutics Reports Fourth Quarter And Full Year 2014 Financial Results "PR Newswire (US)" - 3/24/2015 8:00:00 AM
Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure "PR Newswire (US)" - 3/23/2015 8:00:00 AM
Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure "PR Newswire (US)" - 3/2/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/2/2015 7:47:35 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/2/2015 7:42:10 AM
Mast Therapeutics To Present At Cowen And Company's 35th Annual Healthcare Conference On March 2nd "PR Newswire (US)" - 2/24/2015 8:00:00 AM
Mast Therapeutics Announces New Data Supporting Vepoloxamer In Embolic Stroke "PR Newswire (US)" - 2/11/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2015 8:01:11 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/4/2015 4:48:25 PM
Mast Therapeutics Announces Initiation Of Phase 2a Studies Of AIR001 In Patients With Heart Failure With Preserved Ejection F... "PR Newswire (US)" - 2/4/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/3/2015 8:02:01 AM
Mast Therapeutics To Present At 17th Annual BIO CEO & Investor Conference On February 9th "PR Newswire (US)" - 2/3/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/27/2015 4:35:55 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist